Abstract
Background
In an effort to improve migraine management around the world, the International Headache Society (IHS) has here developed a list of practical recommendations for the acute pharmacological treatment of migraine. The recommendations are categorized into optimal and essential, in order to provide treatment options for all possible settings, including those with limited access to migraine medications.Methods
An IHS steering committee developed a list of clinical questions based on practical issues in the management of migraine. A selected group of international senior and junior headache experts developed the recommendations, following expert consensus and the review of available national and international headache guidelines and guidance documents. Following the initial search, a bibliography of twenty-one national and international guidelines was created and reviewed by the working group.Results
A total of seventeen questions addressing different aspects of acute migraine treatment have been outlined. For each of them we provide an optimal recommendation, to be used whenever possible, and an essential recommendation to be used when the optimal level cannot be attained.Conclusion
Adoption of these international recommendations will improve the quality of acute migraine treatment around the world, even where pharmacological options remain limited.Citations & impact
Impact metrics
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/166256492
Article citations
Enhancing Acute Migraine Treatment: Exploring Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for the Nose-to-Brain Route.
Pharmaceutics, 16(10):1297, 04 Oct 2024
Cited by: 0 articles | PMID: 39458626 | PMCID: PMC11510892
Review Free full text in Europe PMC
Migraine and Pregnancy.
Life (Basel), 14(10):1224, 25 Sep 2024
Cited by: 0 articles | PMID: 39459524 | PMCID: PMC11508317
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Are the current IHS guidelines for migraine drug trials being followed?
J Headache Pain, 11(6):457-468, 08 Oct 2010
Cited by: 8 articles | PMID: 20931348 | PMCID: PMC3476229
Review Free full text in Europe PMC
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults.
Cephalalgia, 39(8):1058-1066, 01 May 2019
Cited by: 1 article | PMID: 31042062
Review
American Headache Society members' assessment of headache diagnostic criteria.
Headache, 43(1):2-13, 01 Jan 2003
Cited by: 10 articles | PMID: 12864752
The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies.
Headache, 64(7):869-872, 03 Jun 2024
Cited by: 0 articles | PMID: 38828836